This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Dr. Perkins' letter was referred to Dr. Acers, offers the following reply.
To the Editor:
Dr. Perkins' letter brings out several most valid and pertinent points. First, he is entirely correct in his statistical analysis of the "relevant" group of patients with posterior chorioretinitis and positive dye test. I misinterpreted his initial presentation and did include all cases with a positive dye-test titer regardless of site of involvement, that is, anterior, posterior, and panuveitis. Perhaps a brief abstract of this statistical presentation is in order for summary and clarification. Dr. Perkins' combined series of patients included a total of 164 uveitis cases. Of this total number of patients 60 presented with an active posterior uveitis. Forty-four patients in this group presented with posterior uveitis and a positive toxoplasmosis dye test. No definitive description of these posterior lesions is given. Twenty-nine of these patients are then discussed in regard to
Acers TE. THERAPY OF TOXOPLASMIC RETINOCHOROIDITIS-Reply. Arch Ophthalmol. 1964;72(3):449–450. doi:https://doi.org/10.1001/archopht.1964.00970020449028
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: